For those of you still interested, found this from a remap-cap twitter link. Jama Network. - Released 11th April 2023
Link: Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA | JAMA Network
Summary:
" In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes."
In terms of DMX-200 - needs someone smarter than me to delve into the details but looks like outcomes were available for only 6 critically ill patients randomized to the combined ARB and DMX-200 intervention prior to trial halt.
Wasn't the main game for sure, but anything good, could only help the share price from here!
For those of you still interested, found this from a remap-cap...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
51.0¢ |
Change
-0.035(6.42%) |
Mkt cap ! $280.3M | |||
| Open | High | Low | Value | Volume |
| 54.0¢ | 54.0¢ | 50.0¢ | $1.454M | 2.822M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 544899 | 51.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 52.0¢ | 104681 | 4 |
View Market Depth
| Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
| DXB (ASX) Chart |